About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: August 21, 2007
New Drug Approval Rate – Not What it Used to Be
In news that doesn’t surprise most of us who have been watching FDA approvals, it would appear that someone has gone and counted up the approval rate and the rate of approvals for new drugs has, in fact, gone down. … Continue reading
Posted in FDA Policy
6 Comments